docetaxel anhydrous has been researched along with Acute Liver Injury, Drug-Induced in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gu, H; Hao, K; Jiang, W; Li, P; Li, S; Lu, Q; Pei, X; Sun, Y; Wang, G; Xu, H | 1 |
| Gao, FF; Hu, PC; Li, Q; Liu, W; Lv, JW; Wang, Y; Wei, L; Xiang, QM | 1 |
| Joerger, M | 1 |
| Chen, X; Ge, Q; Peng, D; Qu, B; Wang, G; Wang, H; Xing, R | 1 |
| Di, L; Dong, N; Liang, X; Lyerly, HK; Ren, J; Song, G; Wang, X; Wang, Z; Yan, Y; Yang, H; Yu, J; Zheng, X; Zhou, X; Zhu, Y | 1 |
| Che, L; Di, L; Jiang, H; Liang, X; Lu, Y; Lyerly, HK; Ren, J; Shao, B; Wang, X; Wang, Z; Yan, Y; Yang, H; Yu, J; Zhang, J; Zhou, X; Zhu, Y | 1 |
| Engelmann, U; Heidenreich, A; Kohlmorgen, S; Ohlmann, CH; Sahi, D | 1 |
| Burris, HA | 1 |
| Alexandre, J; Bensmaïne, A; Bleuzen, P; Bonneterre, J; Chahine, A; Cvitkovic, E; Faivre, S; Guastalla, J; Mahjoubi, M; Marty, M; Misset, JL; Spielman, M; Sutherland, W; Viens, P | 1 |
3 review(s) available for docetaxel anhydrous and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment regimens of classical and newer taxanes.
Topics: Albumins; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Liver; Neoplasms; Paclitaxel; Taxoids; Treatment Outcome; Tubulin Modulators | 2016 |
Optimal use of docetaxel (Taxotere): maximizing its potential.
Topics: Antineoplastic Agents, Phytogenic; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Docetaxel; Hematologic Diseases; Humans; Paclitaxel; Taxoids | 1996 |
2 trial(s) available for docetaxel anhydrous and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
[Lethal course after chemotherapy with docetaxel. Acute liver failure with accompanying erythema multiforme major].
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Chemical and Drug Induced Liver Injury; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Fatal Outcome; Humans; Liver Failure; Liver Function Tests; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Stevens-Johnson Syndrome; Taxoids | 2007 |
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients.
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Breast Neoplasms, Male; Chemical and Drug Induced Liver Injury; Docetaxel; Drug Resistance, Neoplasm; Female; Fever; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neutropenia; Paclitaxel; Prognosis; Risk Factors; Stomatitis; Taxoids; Treatment Outcome | 2000 |
6 other study(ies) available for docetaxel anhydrous and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Docetaxel; Dose-Response Relationship, Drug; Hepatocytes; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Models, Biological; Saponins; Taxoids; Triterpenes; Xenograft Model Antitumor Assays | 2018 |
Protective effect of astragalus polysaccharides on liver injury induced by several different chemotherapeutics in mice.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Astragalus Plant; Caspase 3; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Docetaxel; Epirubicin; Hepatocytes; Liver; Mice; Phytotherapy; Polysaccharides; Taxoids | 2014 |
Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Docetaxel; Drug Interactions; Humans; Saponins; Taxoids; Triterpenes | 2017 |
Non-genetic risk factors and predicting efficacy for docetaxel--drug-induced liver injury among metastatic breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Chi-Square Distribution; Docetaxel; Female; Hepatitis B; Humans; Liver Neoplasms; Logistic Models; Middle Aged; Multivariate Analysis; Odds Ratio; Premenopause; Retrospective Studies; Risk Assessment; Risk Factors; Taxoids | 2012 |
Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Case-Control Studies; Chemical and Drug Induced Liver Injury; Docetaxel; Female; Gene Frequency; Humans; Interleukin-10; Middle Aged; Polymorphism, Single Nucleotide; Taxoids; Tumor Necrosis Factor-alpha | 2013 |